New tracking tech aims to make prostate radiation more accurate
NCT ID NCT01742403
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a method called KIM that tracks the prostate's position during radiation using implanted gold markers. If the prostate moves more than 3mm, the radiation beam stops and is repositioned. The goal is to see if this technique is feasible in 100 men receiving radiation for prostate cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- kV intrafraction monitoring (KIM) with radiation gating
- What this could lead to
- If successful, this technique could make prostate cancer radiotherapy more precise, reducing damage to healthy tissue.
- What could go wrong
- This is a small early feasibility study, not designed to prove treatment effectiveness. The technique may not work in all patients or may add time to procedures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Radiation Oncology, Northern Sydney Cancer Centre
St Leonards, New South Wales, 2065, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can surgery boost control of spread prostate cancer?
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks